
51 - 200 Mitarbeiter
Gegründet 2019
🧬 Biotechnologie
💊 Pharmazie
🔬 Wissenschaft
💰 €85.000.000 Series B im 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics ist ein patientenorientiertes, biopharmazeutisches Unternehmen im klinischen Stadium, das sich auf die Entwicklung von Zelltherapien für Patienten mit Autoimmunerkrankungen konzentriert. Das Unternehmen ist Vorreiter bei CAR-T-Zelltherapien, indem es die transformativen Kräfte von T-Zellen nutzt, um möglicherweise eine anhaltende, behandlungsfreie Remission für Autoimmunerkrankungen zu bieten. Der führende CAR-T-Zelltherapie-Kandidat von Kyverna, KYV-101, befindet sich in klinischen Studien zur Behandlung verschiedener Autoimmunerkrankungen, darunter Multiple Sklerose, Myasthenia gravis, systemische Sklerose und Lupus-Nephritis. Ihre Pipeline umfasst innovative chimäre Antigenrezeptor (CAR)-T-Zelltherapien in sowohl autologen als auch allogenen Formaten, die auf B-Zell-getriebene Autoimmunerkrankungen abzielen.
🕒 vor 27 Tagen
🗣️🇺🇸🇬🇧 Englisch erforderlich
Verbessern Sie Ihre Chancen auf ein Vorstellungsgespräch, indem Sie Ihre Lebenslauf-Bewertung vor der Bewerbung überprüfen.

51 - 200 Mitarbeiter
Gegründet 2019
🧬 Biotechnologie
💊 Pharmazie
🔬 Wissenschaft
💰 €85.000.000 Series B im 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics ist ein patientenorientiertes, biopharmazeutisches Unternehmen im klinischen Stadium, das sich auf die Entwicklung von Zelltherapien für Patienten mit Autoimmunerkrankungen konzentriert. Das Unternehmen ist Vorreiter bei CAR-T-Zelltherapien, indem es die transformativen Kräfte von T-Zellen nutzt, um möglicherweise eine anhaltende, behandlungsfreie Remission für Autoimmunerkrankungen zu bieten. Der führende CAR-T-Zelltherapie-Kandidat von Kyverna, KYV-101, befindet sich in klinischen Studien zur Behandlung verschiedener Autoimmunerkrankungen, darunter Multiple Sklerose, Myasthenia gravis, systemische Sklerose und Lupus-Nephritis. Ihre Pipeline umfasst innovative chimäre Antigenrezeptor (CAR)-T-Zelltherapien in sowohl autologen als auch allogenen Formaten, die auf B-Zell-getriebene Autoimmunerkrankungen abzielen.
• Develop and execute the U.S. sales strategy supporting the commercialization of CAR-T for autoimmune diseases. • Build and lead a best-in-class specialty sales organization capable of supporting current and future product launches. • Establish commercial objectives, territory design, targeting strategies, and deployment models aligned with corporate goals. • Drive revenue growth while ensuring compliance with all regulatory, legal, and company requirements. • Partner with executive leadership to shape long-term commercial strategy and portfolio planning. • Lead commercialization efforts across the CAR-T ecosystem, including treatment centers, referring physicians, infusion centers, and hospital systems. • Develop strategies to optimize treatment center activation, patient identification, referral pathways, and patient access. • Collaborate closely with Market Access, Cell Therapy Operations, Patient Services, and Medical Affairs to ensure seamless therapy adoption. • Understand and address the complexities associated with cell collection, manufacturing, logistics, reimbursement, and site readiness. • Monitor evolving CAR-T market dynamics, competitive intelligence, and emerging treatment paradigms. • Establish and expand relationships with key neurology stakeholders, including academic centers, comprehensive neuroscience programs, and community neurologists. • Drive customer engagement strategies supporting therapies for autoimmune neurological disorders, neurodegenerative diseases, and other complex neurological conditions. • Develop disease-state education and value-based customer engagement approaches. • Partner with Medical Affairs to ensure effective scientific exchange and customer education initiatives. • Recruit, develop, and retain top-performing regional sales leaders and field sales professionals. • Foster a high-performance culture focused on accountability, collaboration, innovation, and patient impact. • Establish performance expectations, coaching programs, succession planning, and talent development initiatives. • Lead ongoing training efforts focused on disease state expertise, clinical data, reimbursement, and customer engagement excellence. • Partner closely with Market Access, Medical Affairs, Marketing, Commercial Operations, Patient Services, Legal, Compliance, and Finance. • Ensure alignment between field execution and broader commercial strategies. • Support forecasting, business planning, resource allocation, and launch readiness activities. • Provide field insights to inform brand strategy, lifecycle planning, and evidence generation priorities. • Establish and monitor KPIs related to sales performance, account engagement, treatment center activation, patient referrals, and market penetration. • Utilize data analytics to optimize territory performance and resource deployment. • Deliver regular business reviews and strategic recommendations to executive leadership. • Identify opportunities to improve commercial effectiveness and customer experience.
• Bachelor's degree required; advanced degree (MBA, PharmD, PhD, or other relevant graduate degree) preferred. • Minimum 15 years of biopharmaceutical commercial experience. • Minimum 8 years of progressive sales leadership experience, including leading national specialty sales teams. • Demonstrated success launching and commercializing specialty, rare disease, neurology, oncology, immunology, or cell and gene therapies. • Deep understanding of specialty reimbursement, payer dynamics, treatment center engagement, and patient access. • Experience managing field teams supporting highly complex therapies and specialized provider networks. • Proven ability to build, lead, and scale high-performing commercial organizations. • Direct CAR-T, cell therapy, gene therapy, or oncology commercialization experience preferred. • Neurology commercialization experience, particularly within autoimmune or rare neurological disorders preferred. • Experience launching products through limited distribution networks and specialized treatment centers preferred. • Strong understanding of buy-and-bill reimbursement models, specialty pharmacy, specialty distribution, and site-of-care considerations preferred.
• This position is also eligible for bonus • benefits • participation in Company’s stock plan
Jetzt Bewerben🕒 vor 27 Tagen
Sales Director responsible for leading the sales cycle and customer solutions at Telus Digital. Requires 3+ years of Salesforce consulting and substantial sales experience.
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 27 Tagen
Director of Sales leading Axon’s Majors Air sales organization in expanding drone technology in public safety. Collaborating with agencies to implement next-generation aerial response programs.
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 27 Tagen
Vice President of Sales driving market growth for Duncan Solutions in photo enforcement. Responsible for developing client relationships and leading complex sales cycles.
🇺🇸 Vereinigte Staaten – Remote
💵 $140.000 - $150.000 / Jahr
💰 Private equity im 2018-10
⏰ Vollzeit
🔴 Experte
🤑 Vertrieb
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 28 Tagen
Vice President of Sales at Ardent Global Logistics overseeing revenue growth and commercial strategy. Leading teams and developing high-performing sales talent in logistics and supply chain.
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 28 Tagen
Sales Director responsible for driving revenue growth and operational excellence at Carlsmed, focusing on spine surgery. Engaging with stakeholders and executing business development strategies in Southern California.
🗣️🇺🇸🇬🇧 Englisch erforderlich